TIMOTHY GLOYD: Open Payments
NPI 1760725204 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,337 in 163 payments from 31 companies in 2025. Trend: 2023 $3,569 · 2024 $2,715 · 2025 $3,337
Food & beverage: $3,337
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $430 |
| Gilead Sciences, Inc. | 19 | $332 |
| ViiV Healthcare Company | 9 | $266 |
| AstraZeneca Pharmaceuticals LP | 5 | $249 |
| Boston Scientific Corporation | 3 | $217 |
| PFIZER INC. | 11 | $170 |
| ABBVIE INC. | 17 | $166 |
| Amgen Inc. | 11 | $136 |
| Abbott Laboratories | 6 | $135 |
| Sumitomo Pharma America, Inc. | 5 | $135 |
Products named: AIRSUPRA, WATCHMAN FLX, DOVATO, GEMTESA, Ozempic, Korlym, ELIQUIS, ZENPEP.
Industry payments across AZ — which companies pay providers there.
